As of 2024-12-13, the Intrinsic Value of Talaris Therapeutics Inc (TALS) is
-8.73 USD. This TALS valuation is based on the model Peter Lynch Fair Value.
With the current market price of 2.72 USD, the upside of Talaris Therapeutics Inc is
-421.08%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-8.73 USD
Intrinsic Value
TALS Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-8.73 - -8.73 |
-8.73 |
-421.08% |
| P/E |
(33.92) - (35.18) |
(33.36) |
-1326.5% |
| DDM - Stable |
(15.24) - (41.61) |
(28.43) |
-1145.1% |
| DDM - Multi |
(0.24) - (0.49) |
(0.32) |
-111.9% |
TALS Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
116.44 |
| Beta |
0.01 |
| Outstanding shares (mil) |
42.81 |
| Enterprise Value (mil) |
98.09 |
| Market risk premium |
5.00% |
| Cost of Equity |
9.90% |
| Cost of Debt |
5.00% |
| WACC |
6.79% |